Yoga and meditation shifted PCOS weight and androgens

Polycystic ovary syndrome sits at the junction of metabolism, hormones and mood: it affects women's metabolic health, reproductive hormones and psychological well-being at the same time. Mindfulness-based approaches such as yoga and meditation are usually offered as stress management, on the assumption that any benefit is purely psychological. That framing leaves an obvious question unanswered — whether structured mind-body practice also moves the physical markers that define the condition, such as body weight, insulin resistance and androgen levels. This review set out to test exactly that, rather than treating mindfulness as a mood intervention alone.

The authors ran a systematic review and meta-analysis of randomised controlled trials of mindfulness-based interventions in women with PCOS, searching databases including PubMed and the Cochrane Library up to January 2025. Ten randomised controlled trials involving 356 participants met the inclusion criteria. Interventions were mindfulness-based practices such as yoga and mindfulness meditation. Outcomes spanned four domains: anthropometric indices, metabolic profiles, reproductive hormones and quality of life. Data were synthesised in Review Manager 5.3, with results expressed as mean differences and standardised mean differences across the pooled trials.

Women in the mindfulness groups showed significant reductions in BMI, body weight and abdominal circumference compared with controls. Insulin resistance measured by HOMA-IR improved, though the authors label this preliminary because it rests on only two studies. On the hormonal side, total testosterone levels and clinical hirsutism both improved. Notably, the psychological picture was mixed: generic depression and anxiety scores did not differ significantly between groups, yet disease-specific quality of life improved significantly. The authors therefore describe mindfulness-based interventions as potential metabolic and endocrine modulators, not simply stress relief.

This complicates the usual assumption that mind-body practice in PCOS works through mood alone — here the psychological questionnaires that would capture that were the outcomes that did not move, while body composition and androgen markers did. It extends earlier work by looking at hormones and metabolism rather than well-being scores in isolation. Big open questions remain: the total evidence base is small, the trials differed in the practices they used and how long they ran, and it is unclear whether the hormonal changes follow from the reductions in weight and waist size or arise independently. Larger trials with consistent protocols are needed.

For anyone managing PCOS, this is a reason to think that yoga or meditation may do more than take the edge off stress, and that its measurable effects could show up in weight, waist circumference and androgen-related symptoms. It is not evidence that mindfulness replaces established metabolic or endocrine care, and the improvement in quality of life was on PCOS-specific measures rather than on general mood scales. The evidence base is small enough that effect sizes should be treated as provisional. What it does support is taking mind-body practice seriously as part of the physical picture, not only the psychological one.